Interestingly, TFF3 was also found to be significantly upregulated in T cell-cold tumors of diverse tissue types, and it was in the top percentile of genes differentially expressed in T cell-cold versus T cell-hot breast cancers (85), which suggests its potential as an immunotherapy target. The gene discussed is TFF3; the disease is breast carcinoma.